CN Stock MarketDetailed Quotes

600420 Shanghai Shyndec Pharmaceutical

Watchlist
  • 12.28
  • -0.19-1.52%
Market Closed Nov 15 15:00 CST
16.47BMarket Cap15.22P/E (TTM)

Shanghai Shyndec Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-6.21%8.59B
-7.52%5.96B
-8.60%3.12B
-6.86%12.07B
-5.73%9.16B
0.90%6.44B
5.33%3.42B
-7.07%12.96B
-9.25%9.72B
-16.31%6.39B
Operating revenue
-6.21%8.59B
-7.52%5.96B
-8.60%3.12B
-6.86%12.07B
-5.73%9.16B
0.90%6.44B
5.33%3.42B
-7.07%12.96B
-9.25%9.72B
-16.31%6.39B
Other operating revenue
----
-49.79%87.58M
----
88.93%282.98M
----
163.15%174.44M
----
-20.77%149.79M
----
-75.43%66.29M
Total operating cost
-13.29%7.15B
-14.87%4.94B
-14.65%2.63B
-8.67%11B
-8.52%8.25B
-2.67%5.8B
1.15%3.08B
-6.64%12.04B
-8.30%9.01B
-14.22%5.96B
Operating cost
-7.45%5.18B
-8.22%3.6B
-9.00%1.85B
-7.23%7.44B
-4.36%5.6B
3.33%3.92B
9.21%2.03B
2.25%8.02B
-1.97%5.86B
-12.05%3.79B
Operating tax surcharges
-3.97%91.85M
3.48%67.55M
32.16%38.4M
20.82%138.12M
18.67%95.65M
19.85%65.28M
3.45%29.06M
-11.67%114.32M
-16.54%80.6M
-16.83%54.47M
Operating expense
-42.03%969.12M
-42.79%716.48M
-36.65%453.6M
-21.59%2.15B
-23.66%1.67B
-16.12%1.25B
-13.14%715.99M
-21.19%2.75B
-20.65%2.19B
-21.93%1.49B
Administration expense
0.71%556.79M
3.83%373.76M
7.40%184.15M
12.59%770.07M
-7.27%552.88M
-11.18%359.97M
-8.04%171.46M
-8.72%683.97M
8.94%596.23M
11.60%405.3M
Financial expense
-29.92%-67.19M
-54.55%-61.56M
-222.74%-21.07M
-63.65%-75.49M
24.61%-51.72M
-56.72%-39.83M
-31.24%17.17M
-146.12%-46.13M
-203.53%-68.6M
-151.42%-25.42M
-Interest expense (Financial expense)
-42.08%27.84M
-50.47%18.7M
-46.32%9.47M
-46.06%57.88M
-43.15%48.06M
-36.80%37.75M
-41.54%17.65M
-2.86%107.31M
-0.62%84.54M
10.27%59.73M
-Interest Income (Financial expense)
-0.78%-74.17M
-10.83%-54.38M
-37.78%-22.84M
-83.71%-109.02M
-81.23%-73.6M
-98.16%-49.07M
-47.38%-16.58M
-21.51%-59.35M
-22.57%-40.61M
-21.07%-24.76M
Research and development
10.43%416.21M
0.42%244.6M
9.92%121.61M
9.31%569.43M
4.67%376.89M
1.69%243.58M
-5.44%110.63M
-11.59%520.92M
-6.77%360.09M
-1.98%239.54M
Credit Impairment Loss
-11.58%-4.01M
78.28%-3.6M
78.39%-2.76M
2.64%18.05M
-175.11%-3.59M
1.47%-16.57M
46.18%-12.75M
170.73%17.59M
116.03%4.78M
61.22%-16.81M
Asset Impairment Loss
-83.11%-93.83M
60.03%-11.31M
76.34%-3.25M
-69.38%-79.11M
-8.26%-51.24M
-33.71%-28.3M
-123.57%-13.74M
73.43%-46.7M
-205.31%-47.34M
-101.55%-21.16M
Other net revenue
792.80%24.6M
298.15%75.47M
257.16%27.75M
-77.62%11.37M
-122.52%-3.55M
-2,157.63%-38.09M
6.18%-17.66M
134.67%50.8M
188.70%15.77M
104.37%1.85M
Fair value change income
----
----
----
----
----
---3.85M
----
----
----
----
Invest income
170.87%36.5M
310.22%16.84M
269.21%2.48M
1,071.97%27.45M
432.67%13.47M
-1,012.23%-8.01M
69.07%-1.47M
109.74%2.34M
74.52%-4.05M
95.96%-720.17K
-Including: Investment income associates
197.21%5.98M
199.66%5.26M
3.98%-1.14M
13.24%5.6M
-88.44%-6.15M
-539.38%-5.28M
75.47%-1.19M
146.51%4.95M
72.18%-3.26M
92.39%-825.61K
Asset deal income
-356.62%-5.49M
-104.08%-2.05M
-2,260.59%-2.2M
-2,785.98%-31.85M
-252.57%-1.2M
-515.62%-1M
-107.35%-93.09K
-644.14%-1.1M
268.09%788.53K
-181.64%-163.14K
Other revenue
134.36%91.44M
284.81%75.59M
221.94%33.47M
-2.37%76.81M
-36.64%39.02M
-51.75%19.64M
-28.26%10.4M
0.91%78.68M
42.40%61.58M
40.00%40.71M
Operating profit
60.80%1.47B
81.30%1.1B
62.77%524.6M
11.95%1.08B
26.55%913.15M
41.28%604.93M
75.97%322.29M
7.64%966.14M
-16.40%721.57M
-33.23%428.16M
Add:Non operating Income
-54.45%10.04M
-57.34%7.75M
-72.33%802.85K
-41.53%25.49M
-44.74%22.05M
110.08%18.17M
-28.44%2.9M
-7.76%43.59M
-22.34%39.9M
-26.72%8.65M
Less:Non operating expense
126.68%21.72M
226.24%18.05M
2,501.30%17.4M
-58.77%10.56M
-46.17%9.58M
-53.01%5.53M
-87.92%668.89K
-3.78%25.61M
-0.91%17.8M
-14.45%11.78M
Total profit
57.38%1.46B
75.92%1.09B
56.54%508M
11.43%1.1B
24.47%925.61M
45.30%617.56M
78.64%324.53M
7.18%984.12M
-17.05%743.66M
-33.51%425.03M
Less:Income tax cost
100.80%257.24M
93.63%199.51M
63.42%82.15M
13.13%131.95M
-8.16%128.11M
8.44%103.04M
10.26%50.27M
20.16%116.63M
44.02%139.49M
-3.29%95.02M
Net profit
50.40%1.2B
72.37%886.89M
55.27%425.86M
11.20%964.61M
32.00%797.5M
55.91%514.52M
101.54%274.26M
5.64%867.48M
-24.45%604.17M
-39.00%330.02M
Net profit from continuing operation
50.40%1.2B
72.37%886.89M
55.27%425.86M
11.20%964.61M
32.00%797.5M
55.91%514.52M
101.54%274.26M
5.64%867.48M
-24.45%604.17M
-39.00%330.02M
Less:Minority Profit
4.85%244.92M
-0.69%168.41M
-0.46%94.6M
13.78%272.73M
31.37%233.58M
61.25%169.58M
62.60%95.04M
-5.21%239.69M
5.68%177.8M
-8.48%105.17M
Net profit of parent company owners
69.27%954.53M
108.29%718.48M
84.83%331.26M
10.21%691.88M
32.26%563.92M
53.41%344.94M
130.87%179.22M
10.47%627.79M
-32.48%426.37M
-47.23%224.85M
Earning per share
Basic earning per share
57.87%0.7117
87.31%0.5357
61.54%0.247
-11.12%0.5433
8.57%0.4508
30.65%0.286
102.25%0.1529
10.46%0.6113
-32.48%0.4152
-47.24%0.2189
Diluted earning per share
57.87%0.7117
87.31%0.5357
79.51%0.247
0.07%0.5433
21.94%0.4508
45.55%0.286
99.71%0.1376
12.52%0.5429
-30.90%0.3697
-45.57%0.1965
Other composite income
-50.74%-111.67K
-51.39%-111.67K
-81.75%90.8K
-109.10%-74.08K
-218.27%-73.77K
-108.42%-33.46K
96.61%497.48K
21.42%814.02K
-105.82%-23.18K
Other composite income of parent company owners
-50.74%-111.67K
-51.39%-111.67K
----
-81.75%90.8K
-109.10%-74.08K
-218.27%-73.77K
-108.42%-33.46K
96.61%497.48K
21.42%814.02K
-105.82%-23.18K
Total composite income
50.40%1.2B
72.37%886.78M
55.29%425.86M
11.14%964.7M
31.81%797.43M
55.90%514.45M
100.93%274.23M
5.67%867.98M
-24.41%604.99M
-39.05%329.99M
Total composite income of parent company owners
69.27%954.41M
108.30%718.37M
84.86%331.26M
10.14%691.97M
31.99%563.85M
53.39%344.87M
129.65%179.19M
10.51%628.29M
-32.42%427.19M
-47.29%224.83M
Total composite income of minority owners
4.85%244.92M
-0.69%168.41M
-0.46%94.6M
13.78%272.73M
31.37%233.58M
61.25%169.58M
62.60%95.04M
-5.21%239.69M
5.68%177.8M
-8.48%105.17M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -6.21%8.59B-7.52%5.96B-8.60%3.12B-6.86%12.07B-5.73%9.16B0.90%6.44B5.33%3.42B-7.07%12.96B-9.25%9.72B-16.31%6.39B
Operating revenue -6.21%8.59B-7.52%5.96B-8.60%3.12B-6.86%12.07B-5.73%9.16B0.90%6.44B5.33%3.42B-7.07%12.96B-9.25%9.72B-16.31%6.39B
Other operating revenue -----49.79%87.58M----88.93%282.98M----163.15%174.44M-----20.77%149.79M-----75.43%66.29M
Total operating cost -13.29%7.15B-14.87%4.94B-14.65%2.63B-8.67%11B-8.52%8.25B-2.67%5.8B1.15%3.08B-6.64%12.04B-8.30%9.01B-14.22%5.96B
Operating cost -7.45%5.18B-8.22%3.6B-9.00%1.85B-7.23%7.44B-4.36%5.6B3.33%3.92B9.21%2.03B2.25%8.02B-1.97%5.86B-12.05%3.79B
Operating tax surcharges -3.97%91.85M3.48%67.55M32.16%38.4M20.82%138.12M18.67%95.65M19.85%65.28M3.45%29.06M-11.67%114.32M-16.54%80.6M-16.83%54.47M
Operating expense -42.03%969.12M-42.79%716.48M-36.65%453.6M-21.59%2.15B-23.66%1.67B-16.12%1.25B-13.14%715.99M-21.19%2.75B-20.65%2.19B-21.93%1.49B
Administration expense 0.71%556.79M3.83%373.76M7.40%184.15M12.59%770.07M-7.27%552.88M-11.18%359.97M-8.04%171.46M-8.72%683.97M8.94%596.23M11.60%405.3M
Financial expense -29.92%-67.19M-54.55%-61.56M-222.74%-21.07M-63.65%-75.49M24.61%-51.72M-56.72%-39.83M-31.24%17.17M-146.12%-46.13M-203.53%-68.6M-151.42%-25.42M
-Interest expense (Financial expense) -42.08%27.84M-50.47%18.7M-46.32%9.47M-46.06%57.88M-43.15%48.06M-36.80%37.75M-41.54%17.65M-2.86%107.31M-0.62%84.54M10.27%59.73M
-Interest Income (Financial expense) -0.78%-74.17M-10.83%-54.38M-37.78%-22.84M-83.71%-109.02M-81.23%-73.6M-98.16%-49.07M-47.38%-16.58M-21.51%-59.35M-22.57%-40.61M-21.07%-24.76M
Research and development 10.43%416.21M0.42%244.6M9.92%121.61M9.31%569.43M4.67%376.89M1.69%243.58M-5.44%110.63M-11.59%520.92M-6.77%360.09M-1.98%239.54M
Credit Impairment Loss -11.58%-4.01M78.28%-3.6M78.39%-2.76M2.64%18.05M-175.11%-3.59M1.47%-16.57M46.18%-12.75M170.73%17.59M116.03%4.78M61.22%-16.81M
Asset Impairment Loss -83.11%-93.83M60.03%-11.31M76.34%-3.25M-69.38%-79.11M-8.26%-51.24M-33.71%-28.3M-123.57%-13.74M73.43%-46.7M-205.31%-47.34M-101.55%-21.16M
Other net revenue 792.80%24.6M298.15%75.47M257.16%27.75M-77.62%11.37M-122.52%-3.55M-2,157.63%-38.09M6.18%-17.66M134.67%50.8M188.70%15.77M104.37%1.85M
Fair value change income -----------------------3.85M----------------
Invest income 170.87%36.5M310.22%16.84M269.21%2.48M1,071.97%27.45M432.67%13.47M-1,012.23%-8.01M69.07%-1.47M109.74%2.34M74.52%-4.05M95.96%-720.17K
-Including: Investment income associates 197.21%5.98M199.66%5.26M3.98%-1.14M13.24%5.6M-88.44%-6.15M-539.38%-5.28M75.47%-1.19M146.51%4.95M72.18%-3.26M92.39%-825.61K
Asset deal income -356.62%-5.49M-104.08%-2.05M-2,260.59%-2.2M-2,785.98%-31.85M-252.57%-1.2M-515.62%-1M-107.35%-93.09K-644.14%-1.1M268.09%788.53K-181.64%-163.14K
Other revenue 134.36%91.44M284.81%75.59M221.94%33.47M-2.37%76.81M-36.64%39.02M-51.75%19.64M-28.26%10.4M0.91%78.68M42.40%61.58M40.00%40.71M
Operating profit 60.80%1.47B81.30%1.1B62.77%524.6M11.95%1.08B26.55%913.15M41.28%604.93M75.97%322.29M7.64%966.14M-16.40%721.57M-33.23%428.16M
Add:Non operating Income -54.45%10.04M-57.34%7.75M-72.33%802.85K-41.53%25.49M-44.74%22.05M110.08%18.17M-28.44%2.9M-7.76%43.59M-22.34%39.9M-26.72%8.65M
Less:Non operating expense 126.68%21.72M226.24%18.05M2,501.30%17.4M-58.77%10.56M-46.17%9.58M-53.01%5.53M-87.92%668.89K-3.78%25.61M-0.91%17.8M-14.45%11.78M
Total profit 57.38%1.46B75.92%1.09B56.54%508M11.43%1.1B24.47%925.61M45.30%617.56M78.64%324.53M7.18%984.12M-17.05%743.66M-33.51%425.03M
Less:Income tax cost 100.80%257.24M93.63%199.51M63.42%82.15M13.13%131.95M-8.16%128.11M8.44%103.04M10.26%50.27M20.16%116.63M44.02%139.49M-3.29%95.02M
Net profit 50.40%1.2B72.37%886.89M55.27%425.86M11.20%964.61M32.00%797.5M55.91%514.52M101.54%274.26M5.64%867.48M-24.45%604.17M-39.00%330.02M
Net profit from continuing operation 50.40%1.2B72.37%886.89M55.27%425.86M11.20%964.61M32.00%797.5M55.91%514.52M101.54%274.26M5.64%867.48M-24.45%604.17M-39.00%330.02M
Less:Minority Profit 4.85%244.92M-0.69%168.41M-0.46%94.6M13.78%272.73M31.37%233.58M61.25%169.58M62.60%95.04M-5.21%239.69M5.68%177.8M-8.48%105.17M
Net profit of parent company owners 69.27%954.53M108.29%718.48M84.83%331.26M10.21%691.88M32.26%563.92M53.41%344.94M130.87%179.22M10.47%627.79M-32.48%426.37M-47.23%224.85M
Earning per share
Basic earning per share 57.87%0.711787.31%0.535761.54%0.247-11.12%0.54338.57%0.450830.65%0.286102.25%0.152910.46%0.6113-32.48%0.4152-47.24%0.2189
Diluted earning per share 57.87%0.711787.31%0.535779.51%0.2470.07%0.543321.94%0.450845.55%0.28699.71%0.137612.52%0.5429-30.90%0.3697-45.57%0.1965
Other composite income -50.74%-111.67K-51.39%-111.67K-81.75%90.8K-109.10%-74.08K-218.27%-73.77K-108.42%-33.46K96.61%497.48K21.42%814.02K-105.82%-23.18K
Other composite income of parent company owners -50.74%-111.67K-51.39%-111.67K-----81.75%90.8K-109.10%-74.08K-218.27%-73.77K-108.42%-33.46K96.61%497.48K21.42%814.02K-105.82%-23.18K
Total composite income 50.40%1.2B72.37%886.78M55.29%425.86M11.14%964.7M31.81%797.43M55.90%514.45M100.93%274.23M5.67%867.98M-24.41%604.99M-39.05%329.99M
Total composite income of parent company owners 69.27%954.41M108.30%718.37M84.86%331.26M10.14%691.97M31.99%563.85M53.39%344.87M129.65%179.19M10.51%628.29M-32.42%427.19M-47.29%224.83M
Total composite income of minority owners 4.85%244.92M-0.69%168.41M-0.46%94.6M13.78%272.73M31.37%233.58M61.25%169.58M62.60%95.04M-5.21%239.69M5.68%177.8M-8.48%105.17M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data